Compare DVA & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DVA | FRHC |
|---|---|---|
| Founded | 1994 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.7B |
| IPO Year | 1995 | N/A |
| Metric | DVA | FRHC |
|---|---|---|
| Price | $110.37 | $133.28 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $145.00 | N/A |
| AVG Volume (30 Days) | ★ 753.4K | 108.4K |
| Earning Date | 02-12-2026 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.63 | N/A |
| EPS | ★ 9.76 | 0.08 |
| Revenue | ★ $13,317,965,000.00 | $1,563,510,000.00 |
| Revenue This Year | $6.50 | N/A |
| Revenue Next Year | $2.97 | N/A |
| P/E Ratio | ★ $11.53 | $1,765.18 |
| Revenue Growth | 5.14 | ★ 16.04 |
| 52 Week Low | $110.33 | $111.85 |
| 52 Week High | $179.60 | $194.01 |
| Indicator | DVA | FRHC |
|---|---|---|
| Relative Strength Index (RSI) | 33.97 | 50.79 |
| Support Level | $110.33 | $120.22 |
| Resistance Level | $115.82 | $137.10 |
| Average True Range (ATR) | 2.42 | 5.24 |
| MACD | -0.23 | 1.03 |
| Stochastic Oscillator | 19.53 | 71.74 |
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.